Test Updates CHISEL

About company 

IRegained is a Digital Neurotherapeutics (DTx) company that has developed the MyHand® System, a FDA Health Canada & HSA registered, patented, smart, neuro-rehabilitation system to “rewire” damaged neural pathways through the power of neuroplasticity, empowering people with a stroke, TBI or musculoskeletal hand injury, reclaim unassisted use of their hands 

About solution 

IRegained has developed the MyHand System, a proprietary targeted hand function rehabilitation system which aims to restore lost hand function in individuals who have sustained a stroke or brain trauma or trauma to the hand from other neuromuscular or musculo-skeletal injuries/disorders. It leverages neuroplasticity, the human brain’s ability to ‘reprogram’ its neural pathways and thereby restore lost hand function.  

 The MyHand® System is an FDA, Health Canada and HSA (Singapore) registered, patented, targeted hand-function rehabilitation system, consisting of a connected mechatronic device, cloud-based proprietary hand-function training protocols, specifically designed therapeutic games that encourage a patient’s active engagement in their therapy. Therapy can be delivered by the mechatronic device both in-person in the clinic, as well as through remote virtual rehabilitation. 

 IReganed’s MyHand® System can be used in rehab centers, recreation clubs and through remote tele-rehabilitation guidance from rehabilitation professionals. Our novel system engages a patient’s sensory system (touch, pressure, and proprioception sensation) and motor capabilities (various hand and forearm muscles) for a more comprehensive rehabilitation approach to help restore hand function. 

Roceso Technologies Private Limited  

About company 

Roceso Technologies is a world-leading neurorehabilitation technology company based in Singapore. Its soft robotic, biosensing and digital health technologies provide functional assistance and neurotherapeutic solutions to patients with functional impairments during rehabilitation and daily living. 

About solution  

Roceso Technologies’ flagship product, the EsoGLOVETM, is one of the world’s lightest hand rehabilitation and exoskeleton devices offering top functionality and comfort. On top of EsoGLOVE, Roceso also developed CygniSENSE Motion, a motion tracking technology based solution for upper limb assessment, exercises and gamification. To achieve telerehab and community care, Roceso launched CygniCONNECT Platform which integrates Roceso’s robotic, biosensing and digital health solutions and enables remote prescription and high-intensity therapy at community and home. 

Lenexa Medical  

About company 

Lenexa Medical is an Australian start-up dedicated to revolutionising the 200-year-old standard of pressure injury care, a persistent yet preventable issue causing pain and suffering to millions worldwide while costing the global healthcare system hundreds of billions each year. 

About solution 

LenexaCARE utilises fabric-based sensors and AI-driven image recognition to convert a traditional medical mattress into a smart patient monitoring system. Data captured discreetly through LenexaCARE enables precise, continuous tracking of patient positions and pressure areas, providing clinicians and carers with actionable data to finally allow for proactive and accountable pressure injury prevention. The solution incorporated into the mattress cover means residents and patients can be monitored in comfort and with dignity without the impracticalities of wearables and the discomfort caused by cameras. Future applications will enable the system to become a complete patient and resident monitoring suite including sleep monitoring, falls risk reduction, vitals monitoring and more features that will be included as software updates. 

SG Diagnostics Pte Ltd  

About company 

SG Diagnostics is a medical device company specializing in point-of-care testing for chronic diseases, including HbA1c and lipid profile tests. Our mission is to enhance lives by empowering individuals with greater health awareness through accessible and accurate testing. 

About solution  

Our proposed solution, the PreciS Health Management System, is designed to enhance the chronic diseases management in Singapore and beyond, particularly for high-risk elderly individuals who may not regularly access healthcare services. By raising public health awareness and improving aging-related chronic disease management, we aim to benefit both the public health and individuals. 

In partnership with SGO, we will introduce a door-to-door health screening initiative, involving visiting homes to perform point-of-care tests for key health parameters such as HbA1c, a full lipid profile, and blood pressure, utilizing our handheld analyzers. 

Powered by the HbA1c handheld solution, co-developed by SG Diagnostics and the National Healthcare Group, the screening process is streamlined and efficient. All data will be securely stored in the cloud and, ideally, shared in real-time with healthcare providers to facilitate immediate follow-up and care. 

Beyond health screenings, we will use this opportunity to educate individuals on chronic disease management, including key programs such as Healthier SG, the War on Diabetes initiative, and practical diabetes management tips. Our solution aims to advance early detection and awareness of chronic diseases, enhance public health efforts, and support timely intervention and better health management within the community. 

Occutrack Medical Solutions Pte Ltd 

About company 

Occutrack is developing a home eye-tracking system to monitor age-related macular degeneration (AMD), improving patient compliance by reducing clinic visits. This enables timely assessments and interventions to prevent vision loss and enhance quality of life for AMD patients. 

About solution  

Occutrack is a medical startup developing an eye movement tracking AI ‘CRYSTALSIGHT’ for home use to monitor and manage visual deterioration. The focus is on age-related macular degeneration (AMD) using advanced eye-tracking AI. Occutrack’s CRYSTALSIGHT gaze interrogation algorithm tracks eye movements in response to visual stimuli, analyzes the data for abnormalities, and assesses visual performance. This non-invasive process helps detect and monitor conditions like AMD, allowing for convenient home-based eye health management. Normal human vision consists of a series of quick eye movements called saccades. These rapid eye movements have ballistic behaviour and abruptly change the fixation point depending on the area of the person's eye. By tracking these optokinetic movements with displayed patterns on the screen, the health of one’s eyes can be determined. 

About company 

Mediktor is a leading company in the medical technology field with more than 10 years of market experience and a presence in 35 countries. Mediktor has developed the most advanced all-in-one platform that simplifies patient management with an empathy-driven AI healthcare assistant, with a number of international healthcare institutions, including hospitals. 

About solution  

Mediktor is powered by a sophisticated Natural Language Processing AI engine that enables users to converse naturally in 18 languages, the white-labeled SaaS is omnichannel and can be easily embedded into any interface, a solution adaptable to multiple business needs. Its AI assists patients and guides them through a series of questions to get a list of personalised recommendations and possible diagnoses. Thanks to its Machine Learning, it offers a highly personalized experience to users, leveraging this technology to extract key information and learn from every input users explain during symptom evaluations. NLP technology allows users to express themselves using their words, even if misspelt, conversing naturally with the chatbot. Mediktor helps Hospitals and Health Systems leading patients efficiently and safely to the most appropriate healthcare service. For healthcare professionals, Mediktor Plus offers support during triage, accelerating patient assessment and reducing waiting times. Doctors can also save time by leveraging triage information for discharge reports. As the first AI-based emergency triage tool, Mediktor helps alleviate the burden on emergency departments. Its integration with Hospital Information Systems streamlines treatments and protocols. 

CAPTUREPROOF, INC 

bout company 

CaptureProof is a HIPAA-compliant digital health platform that leverages AI-powered video and photo analysis to enable patient monitoring and assessment. Through the Smart Medical Camera™, CaptureProof captures visual biometrics, providing healthcare professionals with objective, longitudinal data to enhance diagnosis, treatment, and patient care across various medical conditions from anywhere. 

About solution  

BalanceScan, powered by CaptureProof, revolutionizes fall risk assessment by utilizing AI-driven video analysis to evaluate mobility and balance with clinical precision. Through simple smartphone or tablet recordings, BalanceScan conducts Sit to Stand or Timed Up and Go (TUG) tests and other critical assessments to measure gait, listing angles, and functional movements in real-time. By capturing and analyzing subtle changes in a patient's movements, BalanceScan provides actionable insights that allow healthcare professionals to intervene early, reducing fall risks and improving patient outcomes. 

With proven accuracy in identifying fall risks—validated in clinical studies—BalanceScan offers a practical, scalable solution for fall prevention in elderly populations. The platform integrates seamlessly into clinical workflows, enabling both in-office and remote assessments, making it a powerful tool for continuous patient monitoring. Beyond fall risk, BalanceScan’s technology can be applied across various medical disciplines, offering a horizontal application that extends from emergency departments to specialty care settings. 

BalanceScan not only enhances patient safety but also reduces healthcare costs associated with falls, potentially saving millions in hospital admissions. With its commitment to innovation and improving quality of care, BalanceScan aligns perfectly with initiatives aimed at supporting active aging and community-based healthcare. 

About company 

ViewMind is revolutionizing brain health with its First-In-Class technology that combines eye movement analysis with machine learning. Our non-invasive, highly accurate cognitive assessments detect subtle changes in cognition, enabling early diagnosis, prevention, and monitoring of brain conditions in a scalable, objective, and culturally neutral manner. 

About solution  

ViewMind is transforming the landscape of brain health with its First-In-Class technology that merges eye movement analysis with advanced machine learning. Our platform offers highly accurate, non-invasive cognitive assessments by detecting fine-grain changes in cognition through the eyes. This innovative approach allows for early diagnosis, prevention, and continuous monitoring of brain conditions. 

What sets ViewMind apart is its ability to provide objective and scalable assessments that are culturally neutral, making them accessible across diverse populations. Unlike traditional methods, which can be invasive, costly, and dependent on the evaluator’s expertise, ViewMind’s 20-minute evaluations are easy to administer, and do not require specialized training. 

Our technology is designed for early detection and for the monitoring of disease progression and treatment impact. By enabling healthcare providers to make data-driven decisions, ViewMind enhances patient outcomes and reduces healthcare costs. With its scalable and efficient approach, ViewMind is poised to become a key tool in the fight against brain health disorders, driving innovation in cognitive assessment and care. 

Dr Lee Fook Kay heads Temasek Foundation’s Pandemic X Office that develops and executes philanthropic outreach and projects for preparedness and countermeasures for future pandemics. His office supports regional networking of scientific communities and health policy makers, and capacity building through science and technology sharing. It also catalyses efforts for biobanking to promote data and material sharing in scientific networks and surveillance of emerging infections and neglected tropical diseases with pandemic potential.

Dr Lee was Chief Scientist of Ministry of Home Affairs before he retired from civil service and joined Temasek Foundation. He was instrumental in building national S&T capabilities in chemical, biological, radiological, and nuclear defence for national security during his career with the Ministries of Defence and Home Affairs. He graduated with PhD in Chemistry from National University of Singapore in 1990 and was designated as Chartered Chemist in 1994 by UK Royal Society of Chemistry.

Mr Colin Lim is the Chief Information Officer and Chief Data Officer at Singapore’s Ministry of Health.

His previous role was the Chief Executive Officer of mobilityX, a mobility as a service startup, that was backed by SMRT and Toyota Tsusho. Prior to that, Colin was Managing Director SMRT Services and Vice President, Strategic Relations Office SMRT. He earlier worked at IBM UK, where his last role was Geography Leader, Intelligent Transport Systems, then a new IBM business initiative for which he identified and developed new markets and opportunities for IBM globally.

Colin also served in the Singapore Administrative Service where his last appointment was Senior Director of the Planning and Organisation Division in the Ministry of Home Affairs. Prior to that, he was the Registrar of Vehicles and Group Director for Vehicle and Transit Licensing at the Land Transport Authority. He has also worked at the Ministries of Manpower and Transport.

Colin holds a Master of Business Administration from the University of Oxford and a Bachelor of Science (Economics) (Honours) from the London School of Economics on a Public Service Commission scholarship.  

Mr Edwin Chew is currently the Chief Digital Strategy Officer for the Agency for Integrated Care (AIC). He leads a team to support the Singapore community care sector digitalization uplifting journey. He also manages the IT needs of AIC which supports the long-term care sector.

Prior to AIC, Edwin was the Program Director at the Integrated Health Information Systems Pte Ltd, a wholly owned subsidiary of MOH Holdings. In his role as the Program Director, he managed a team of healthcare IT professionals to support the 3 Singapore Public Healthcare Clusters. He program-managed and developed IT systems for use in the public healthcare domain areas such as electronic medical records, pharmacy closed-loop medication, laboratory, radiology and specialties including ICU, ENT, Ophthalmology, dental clinics, operating theatres. He is also involved in enabling the IT capabilities for the new healthcare buildings. Separately, Edwin also took on the role as the CIO for Woodlands Health Campus (2014 to 2017) and IT Director Tan Tock Seng Hospital (2009 to 2011).

With a career of over 20 years of IT experience in banking and healthcare industry, Edwin has implemented many large-scale banking and healthcare projects.

Edwin graduated with a Bachelor of Science (Computing) from Swinburne University of Technology, Australia and he holds a Master of Business Administration from University of Adelaide, Australia. He is also a Certified IT Project Manager (Senior) by the Singapore Computer Society (SCS).

As the Chief Executive Officer for Synapxe, Ms Ngiam Siew Ying plays a key role in the master-planning and development of Health technology to advance healthcare transformation, and improve population health amidst a dynamic and complex health eco-system.

Siew Ying entered Public Service in 1999. Prior to her appointment in Synapxe, she was Deputy Secretary (Policy) in the Ministry of Health where she led the development of systems planning, finance and corporate policies.

Through her career, Siew Ying has held various appointments in the National Population and Talent Division under the Prime Minister’s Office, Ministry of Transport, Ministry of Defence, and the Defence Science and Technology Agency.

Ms Loh Shu Ching is the Chief Community Care in the NHG Population Health Campus with 30 years of healthcare experience spanning from acute hospital administration and operations work, running community care organisations to overseeing population health management.

She started her healthcare career in TTSH rotating through various administrative and operations units before joining the Community Care sector as General Manager of Home Nursing Foundation and subsequently as the CEO of Ren Ci Hospital.  Prior to her current role, she was overseeing the population health management work anchored by TTSH as part of the Central Health Integrated Care Network to serve the residents in the Central region.

As Chief Community Care, Shu Ching oversees the NHG community care services serving 2.2 million residents in Central North Singapore.  Her responsibilities include the planning and development of population health initiatives in the areas of Preventive Health and Wellness, School and Workplace Health, Community and Aged care, and care transitions between the hospital and community.

Adj Asst Prof Chua Chi Siong is Medical Director (MD), Regional Health System Office (RHSO), National University Health System (NUHS). He provides clinical leadership and oversight for health-related interactions with residents in consultation with community partners and ensure the quality of care and clinical services provided by RHSO. He also provides strategic inputs to the development and implementation of NUHS population health strategy.

Adj Asst Prof Chua was Medical Director, Jurong Community Hospital (JCH) from 2011-2022, where he oversees the planning, opening and ramp up of JCH. He continues to be the Head, Clinical Quality as well as the senior consultant, Post-Acute and Continuing Care Department in JCH.

Prof Lee is the Deputy Group CEO (Regional Health System), SingHealth where he leads population health efforts; and chairs the Planning Committee for the upcoming Eastern General and Community Hospitals.

Prof Lee is an Adjunct Professor at the Saw Swee Hock School of Public Health, NUS; Duke-NUS Medical School and SUTD.   He had served on international committees under WHO, IHF and JCI.